Please login to the form below
MSD
This page shows the latest MSD news and features for those working in and with pharma, biotech and healthcare.
MSD and AstraZeneca announce phase 3 results for prostate cancer therapy
MSD – known as Merck &Co in the US and Canada – and AstraZeneca have shared positive results from the PROpel phase 3 trial for the combination therapy of Lynparza (olaparib) plus abiraterone
Latest news
-
FDA delays Merck’s pneumococcal vaccine Vaxneuvance
Merck &Co – known as MSD outside the US and Canada – has announced that the US Food and Drug Administration (FDA) has extended the date of the company’s application for its
-
Merck’s Keytruda receives FDA approval for advanced endometrial cancer
Merck &Co – known as MSD outside the US and Canada – has announced that Keytruda (pembrolizumab) has been approved by the US Food and Drug Administration (FDA) for advanced endometrial cancer.
-
AstraZeneca and MSD’s breast cancer drug Lynparza receives FDA approval
AstraZeneca (AZ) and MSD – known as Merck &Co in the US and Canada – have announced that the companies’ jointly developed drug Lynparza (olaparib) has been approved by the US Food and
-
MSD and Curve Therapeutics agree on deal potentially worth $1.7bn
MSD will lead the optimisation, clinical development, manufacturing and commercialisation of compounds identified through the collaboration. ... Working with MSD on selected therapeutic targets will complement Curve’s in-house drug discovery and
-
Merck and Ridgeback fulfil US deal for molnupiravir
Merck &Co – known as MSD outside the US and Canada – and Ridgeback Biotherapeutics have announced that approximately 3.1 million courses of its investigational oral antiviral COVID-19 treatment, molnupiravir, have
More from news
Approximately 81 fully matching, plus 405 partially matching documents found.
Latest Intelligence
-
Alzheimer’s disease: the search for a cure
The companies, Abbvie, Astex Pharmaceuticals, Eisai, Johnson &Johnson, Lilly, MSD and Takeda, Evotec and Charles River, participate in research projects alongside academic scientists.
-
NICE – but not enough
A great example is Steglatro, MSD’s treatment for type 2 diabetes. ... Armed with positive NICE guidance, MSD did a great job of getting Steglatro on formulary.
-
Switzerland: a life sciences hub
The country is thus home to AbbVie, Allergan, Amgen, AstraZeneca, Bayer, Biogen, Boehringer Ingelheim, Eli Lilly, Gilead, GlaxoSmithKline, Janssen, Lundbeck, MSD (Merck Sharp &Dohme), Pfizer, Sanofi and Takeda among others.
-
Guiding star of science leads AstraZeneca to breakthrough in child tumour therapy
It is being developed in a strategic partnership with Merck &Co/MSD, formed in 2017, to maximise the potential of PARP and MEK inhibitors.
-
Why pharma should invest in the education of doctors
By Tim Russell, VP Head of Business Development, M3 (EU); Heather Hancock, Business and Commercial Operations Director, MSD UK and Deepak Jadon, a consultant rheumatologist at Cambridge University Hospitals NHS FT
More from intelligence
Approximately 4 fully matching, plus 35 partially matching documents found.
Latest appointments
-
ENGINE MHP+Mischief bolsters healthcare comms expertise with new senior hires
She has also worked in roles at MSD, M&C Saatchi, the House of Commons and NCT.
-
GCI Health’s UK team announces three senior promotions
Before joining GCI Health, Yianni (pictured left) worked at pharmaceutical company MSD as a strategic project manager.
-
Merck & Co appoints Frank Clyburn as president, human health
Merck &Co – known as MSD outside the US and Canada – has appointed Frank Clyburn (pictured above) as president, human health.
-
Dan Russell joins Seven Stones as managing director
Pharmaceuticals, MSD and more.
-
New hires at Ashfield, Hamell and Springer Healthcare
Mitchelson has over 15 years’ experience in the pharmaceutical and healthcare industry, and has held roles at MSD, Langland and Havas Lynx.
More from appointments
Approximately 5 fully matching, plus 51 partially matching documents found.
Latest from PMHub
-
Lucid Group Bolster its Senior Leadership Team
The majority of Jo’s 15 years within pharma were spent at Sanofi Pasteur MSD where she held a number of senior marketing roles before moving agency-side to STEM, holding
-
Mednet Group
Johnson and Johnson. University of Leeds. Lundbeck Mind. MSD. Novo. Nordisk.
-
Onyx Health Expands with New Management Appointment
business such as Boots, the ProPharma Group and MSD.
-
HOW INNOVATION IS RESHAPING THE NORTH EAST LIFE SCIENCES LANDSCAPE
We have an enviable cluster of world class pharmaceutical manufacturers on our doorstep including Glaxo Smith Kline, MSD and Piramal Healthcare.
-
Wearables and healthcare
So impressive was the success of SCI-diabetes, the Scottish Government in collaboration with various stakeholders including MSD Healthcare Services, decided to unlock the data potential of the entire nation’s
More from PMHub
Approximately 0 fully matching, plus 16 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- My journey advancing the science in pulmonary hypertension
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- FDA issues innovative proposal to increase nonprescription drug access
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- NHS App to revolutionise digital health and care with major digital updates by 2023
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- GSK announces The HealthTree Foundation’s multiple myeloma programme as first ‘Think Tank’ challenge winner
- NRG Therapeutics partners with Domainex to develop neurodegenerative disease treatment
- Innovative Trials opens first US office
- Scanning for Health Indicators and Risks Through Your Smartphone
- College of Medicine launches Beyond Pills campaign to tackle overprescribing in UK health system
- AI is transforming pharma R&D – now it can transform pharma marketing
- Armoured CAR ‘could overwhelm solid tumour resistance’
- Six UK universities receive grant for research into motor neurone disease
- Realising the potential of omnichannel in medical communications
- Improving childhood cancer survival rates in developing countries
PMHub
Aptus Health
Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
